All‐cause mortality during hospital stay · preterm or very low birth weight infants
It is very uncertain whether summary of findings table ‐ Silicone earplugs changes all‐cause mortality during hospital stay compared with no earplugs (very low certainty).
1 finding from 1 review
Weight (kg) · preterm or very low birth weight infants
1 finding from 1 review
Height (cm) · preterm or very low birth weight infants
1 finding from 1 review
Duration of mechanical ventilation · preterm or very low birth weight infants
1 finding from 1 review
Days of initial hospitalisation · preterm or very low birth weight infants
1 finding from 1 review
Time to reach full sucking feeds (days) · preterm infants
1 finding from 1 review
Adverse effects related to intervention · preterm infants
1 finding from 1 review
Duration (days) of parenteral nutrition · preterm infants
1 finding from 1 review
Time to achieve full enteral feeding (days) · preterm infants
1 finding from 1 review
Feeding intolerance during hospitalisation (resulting in discontinuation of or reduction in enteral feeding) · preterm infants
1 finding from 1 review
Necrotising Enterocolitis ≥ Bell's stage 2 during initial hospital stay · preterm infants
Exposure showed no clear difference in necrotising enterocolitis during hospitalisation (Bell's stage ≥ 2) compared with no exposure to the smell and taste of milk with tube feeds (low certainty).
1 finding from 1 review
Treatment non‐acceptability (higher = greater non‐acceptability): end‐of‐intervention · older people with depression
1 finding from 1 review
Quality of life or psychological well‐being (higher = higher quality of life or psychological well‐being): end‐of‐intervention · older people with depression
1 finding from 1 review
Anxious symptomatology (lower = less anxious symptomatology): end‐of‐intervention · older people with depression
1 finding from 1 review
Change in eGFR · preventing the progression of CKD
1 finding from 1 review
Serious adverse events ( · preventing the progression of CKD
Metformin showed no clear difference in serious adverse events ( compared with active control (moderate certainty).
1 finding from 1 review
Withdrew due to intolerance ( · preventing the progression of CKD
Metformin showed no clear difference in withdrew due to intolerance ( compared with active control (moderate certainty).
1 finding from 1 review
Dosing and tolerance ( · preventing the progression of CKD
1 finding from 1 review
Kidney failure · preventing the progression of CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
UACR (% change) ( · preventing the progression of CKD
1 finding from 1 review